Emmessar Biotech And Nutrition (BOM:524768) Quick Ratio: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524768 Emmessar Biotech And Nutrition Ltd BOM:524768
51 GF Score
Price ₹24.00
GF Value ₹18.26
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Emmessar Biotech And Nutrition Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Emmessar Biotech And Nutrition's quick ratio for the quarter that ended in Jun. 2026 was .

Emmessar Biotech And Nutrition has a quick ratio of . It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Emmessar Biotech And Nutrition's Quick Ratio or its related term are showing as below:

BOM:524768' s Quick Ratio Range Over the Past 10 Years
Min: 0.99   Med: 7.41   Max: 16.31
Current: 12.53

During the past 13 years, Emmessar Biotech And Nutrition's highest Quick Ratio was 16.31. The lowest was 0.99. And the median was 7.41.

BOM:524768's Quick Ratio is ranked better than
96.49% of 998 companies
in the Drug Manufacturers industry
Industry Median: 1.4 vs BOM:524768: 12.53

Emmessar Biotech And Nutrition  (BOM:524768) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Emmessar Biotech And Nutrition Quick Ratio Related Terms


Emmessar Biotech And Nutrition Quick Ratio Historical Data

* Premium members only.

The historical data trend for Emmessar Biotech And Nutrition's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emmessar Biotech And Nutrition Quick Ratio Chart

Emmessar Biotech And Nutrition Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.52 13.82 13.38 15.41 12.53

Emmessar Biotech And Nutrition Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.81 12.53

BOM:524768 vs ZTS: Quick Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Emmessar Biotech And Nutrition's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Emmessar Biotech And Nutrition Quick Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emmessar Biotech And Nutrition's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Emmessar Biotech And Nutrition's Quick Ratio falls into.


BOM:524768
51GF Score
Emmessar Biotech And Nutrition Ltd BOM:524768
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Emmessar Biotech And Nutrition Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Emmessar Biotech And Nutrition's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Quick Ratio (A: Mar. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(80.581-0.972)/6.356
=12.53

Emmessar Biotech And Nutrition's Quick Ratio for the quarter that ended in Jun. 2026 is calculated as

Quick Ratio (Q: Jun. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(-0)/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Emmessar Biotech And Nutrition (BOM:524768) Overvalued in 2026?

Based on GuruFocus' analysis, Emmessar Biotech And Nutrition stock appears to be overvalued. The current stock price of ₹24.00 is trading 31.4% above its estimated GF Value™ of ₹18.26. GuruFocus considers Emmessar Biotech And Nutrition to be Significantly Overvalued.

Key valuation signals for BOM:524768:

  • Quick Ratio:
  • GF Value™: ₹18.26 vs. price of ₹24.00 (31.4% above fair value)
  • GF Score™: 51/100 with 1 warning sign

No single metric tells the full story. See the BOM:524768 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Emmessar Biotech And Nutrition Business Description

Address 38, Cawasji Patel Street, 29, Kamer Building, 4th floor, Fort, Mumbai, MH, IND, 400001
Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.
51GF Score

Get the complete analysis for BOM:524768

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹24.00
Price
₹18.26
GF Value